These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10611897)

  • 1. Improving management of type 2 diabetes mellitus: 4. Meglitinides.
    Quillen DM; Kuritzky L; Samraj GP
    Hosp Pract (1995); 1999 Dec; 34(13):38-40. PubMed ID: 10611897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapaglinide: Novonorm, an alternative in type 2 diabetes].
    Bouhanick B; Barbosa SS
    Presse Med; 2000 May 27-Jun 3; 29(19):1059-61. PubMed ID: 10874917
    [No Abstract]   [Full Text] [Related]  

  • 3. [Repaglinide].
    Quast U
    Dtsch Med Wochenschr; 2001 May; 126(19):559-60. PubMed ID: 11402913
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
    Owens D
    J Assoc Physicians India; 2001 Jan; 49 Spec No():54-61. PubMed ID: 11235607
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.
    Khamaisi M
    Diabet Med; 2012 Sep; 29(9):1214-5. PubMed ID: 22414218
    [No Abstract]   [Full Text] [Related]  

  • 7. [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
    Drug Ther Bull; 2003 Jul; 41(7):52-4. PubMed ID: 12879789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials.
    Yin J; Deng H; Qin S; Tang W; Zeng L; Zhou B
    Diabetes Res Clin Pract; 2014 Sep; 105(3):e10-5. PubMed ID: 25005849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity to repaglinide.
    Rojas P; Sánchez L; Santos A; Góõmez MP; Blanco H; Laguna JJ
    J Investig Allergol Clin Immunol; 2011; 21(3):245-7. PubMed ID: 21548456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide, a novel, short-acting hypoglycemic agent for type 2 diabetes mellitus.
    Guay DR
    Pharmacotherapy; 1998; 18(6):1195-204. PubMed ID: 9855316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honing type 2 diabetes treatment.
    Blackburn G
    Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405
    [No Abstract]   [Full Text] [Related]  

  • 12. Repaglinide for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1998 May; 40(1027):55-6. PubMed ID: 9618664
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin secretagogues.
    Kock M
    J Assoc Physicians India; 1997; Suppl 1():48. PubMed ID: 11235637
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug knowledge is critical.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Jul; 98(7):14. PubMed ID: 9663123
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".
    Jiang DQ; Li MX; Wang Y
    Diabetes Res Clin Pract; 2015 Apr; 108(1):e1-2. PubMed ID: 25747159
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed hypoglycemia induced by repaglinide in a frail elderly adult with diabetes mellitus.
    Mennecart M; Mondon K; Malherbe C; Constans T
    J Am Geriatr Soc; 2014 Dec; 62(12):2460-2. PubMed ID: 25516054
    [No Abstract]   [Full Text] [Related]  

  • 17. Mild, reversible pancytopenia induced by rosiglitazone.
    Maaravi Y; Stessman J
    Diabetes Care; 2005 Jun; 28(6):1536. PubMed ID: 15920093
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of rapid insulin secretion: revisited.
    Grodsky GM
    Diabetes Technol Ther; 1999; 1(3):259-60. PubMed ID: 11475271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Large general practice study with repaglinide. Fewer "anxiety eating" in diabetic patients].
    MMW Fortschr Med; 2001 Mar; 143(10):47-8. PubMed ID: 11277117
    [No Abstract]   [Full Text] [Related]  

  • 20. Repaglinide dose response? A clinician's viewpoint.
    Schade DS
    Diabetes Technol Ther; 1999; 1(3):257-8. PubMed ID: 11475270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.